![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Asunaprevir Pharmacokinetics and Safety in Subjects With Impaired Renal Function
|
|
|
Reported by Jules Levin
AASLD 2013 Nov 1-5 Wash DC
Garimella T,1 He B,1 Luo W-L,2 Colston E,1 Zhu K,1 Kandoussi H,2 Marbury T,3 Alcorn H,4 Smith W,5 Eley T1
1Bristol-Myers Squibb, Hopewell, NJ; 2Bristol-Myers Squibb, Lawrenceville, NJ; 3Orlando Clinical Research Center, Orlando, FL;
4DaVita Clinical Research, Minneapolis, MN; 5New Orleans Center for Clinical Research, Knoxville, TN
![AASLD1.gif](../images/120413/120413-6/AASLD1.gif)
![AASLD2.gif](../images/120413/120413-6/AASLD2.gif)
![AASLD3.gif](../images/120413/120413-6/AASLD3.gif)
![AASLD4.gif](../images/120413/120413-6/AASLD4.gif)
![AASLD5.gif](../images/120413/120413-6/AASLD5.gif)
![AASLD6.gif](../images/120413/120413-6/AASLD6.gif)
![AASLD7.gif](../images/120413/120413-6/AASLD7.gif)
![AASLD8.gif](../images/120413/120413-6/AASLD8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|